Buprenophine-wafer for drug substitution therapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/485 (2006.01) A61K 9/20 (2006.01) A61K 9/70 (2006.01) A61P 25/04 (2006.01)

Patent

CA 2661759

The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug- dependent human subjects.

La présente invention concerne des formes orales pharmaceutiques comprenant de la buprénorphine, la forme pharmaceutique libérant instantanément la buprénorphine dès l'application orale de la forme pharmaceutique, de préférence sous la langue. La présente invention concerne également l'utilisation de telles formes pharmaceutiques pour le traitement de la douleur chez l'homme ou l'animal ou dans le cadre d'un traitement de substitution lié à la toxicomanie chez des sujets humains.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Buprenophine-wafer for drug substitution therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Buprenophine-wafer for drug substitution therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buprenophine-wafer for drug substitution therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1603289

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.